GeNO, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
GeNO, LLC - overview
Location
Lexington, MA, US
Primary Industry
Biotechnology
About
GeNO, LLC is an innovative company specializing in AI-driven design solutions that empower businesses to create distinctive branding and logo materials, enhancing their market presence effectively. GeNO, LLC focuses on providing advanced design services to facilitate unique branding experiences. Headquartered in Lexington, US, the company was co-founded by Brent Furse and Drew Genovesi. The company has successfully secured funding, raising a total of USD 14.
57 mn as of October 2, 2013, through various investment rounds, with the latest round being an unspecified amount. GeNO, LLC specializes in AI-driven design solutions, offering a platform that includes a logo maker featuring customizable fonts and 3D artwork. Their services cater to small to medium-sized businesses, startups, and individual entrepreneurs. The platform also provides tools for customer engagement, including branded templates for web content and social media, focusing primarily on markets in North America and Europe.
GeNO, LLC operates on a direct-to-consumer revenue model for its AI-powered design tools and services, allowing clients to engage through subscription plans or one-time purchases for branding materials. Their flagship products, including the logo maker and custom templates, form the core of their revenue strategy, providing immediate access to design tools and enhancing brand visibility for users. GeNO, LLC plans to leverage the recent funding of USD 14. 57 mn raised in October 2013 to support the development of new design tools and features.
The company aims to expand its operations into additional markets, particularly targeting regions in Asia and South America by 2025. This strategic growth initiative will focus on enhancing their product offerings and reaching a broader audience in the competitive digital branding landscape.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.genollc.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.